153 related articles for article (PubMed ID: 35845310)
1. Clinical significance of TRIM29 expression in patients with gastric cancer.
Farhadi J; Mehrzad J; Mehrad-Majd H; Motavalizadehkakhky A
Gastroenterol Hepatol Bed Bench; 2022; 15(2):131-138. PubMed ID: 35845310
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer.
Afshar J; Mehrzad J; Mehrad-Majd H; Goshayeshi L; Saeidi J
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2445-2451. PubMed ID: 34452557
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection.
Wang C; Zhou Y; Chen B; Yuan W; Huang J
Oncol Lett; 2018 Apr; 15(4):5792-5798. PubMed ID: 29556308
[TBL] [Abstract][Full Text] [Related]
4. Significance of TRIM29 and β-catenin expression in non-small-cell lung cancer.
Zhou ZY; Yang GY; Zhou J; Yu MH
J Chin Med Assoc; 2012 Jun; 75(6):269-74. PubMed ID: 22721621
[TBL] [Abstract][Full Text] [Related]
5. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
6. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185.
Qiu F; Xiong JP; Deng J; Xiang XJ
Int J Clin Exp Pathol; 2015; 8(5):5053-61. PubMed ID: 26191199
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.
Goshayeshi L; Afshar J; Mehrad-Majd H
Asian Pac J Cancer Prev; 2022 May; 23(5):1725-1731. PubMed ID: 35633558
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.
Farhadi J; Goshayeshi L; Motavalizadehkakhky A; Mehrzad J; Mehrad-Majd H
J Gastrointest Cancer; 2022 Mar; 53(1):179-186. PubMed ID: 33415720
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer.
Song X; Fu C; Yang X; Sun D; Zhang X; Zhang J
Oncol Lett; 2015 Oct; 10(4):2283-2288. PubMed ID: 26622835
[TBL] [Abstract][Full Text] [Related]
10. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.
Jiang T; Tang HM; Lu S; Yan DW; Yang YX; Peng ZH
Med Oncol; 2013 Dec; 30(4):715. PubMed ID: 24078150
[TBL] [Abstract][Full Text] [Related]
12. Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.
Kosaka Y; Inoue H; Ohmachi T; Yokoe T; Matsumoto T; Mimori K; Tanaka F; Watanabe M; Mori M
Ann Surg Oncol; 2007 Sep; 14(9):2543-9. PubMed ID: 17597343
[TBL] [Abstract][Full Text] [Related]
13. TRIM29 facilitates the epithelial-to-mesenchymal transition and the progression of colorectal cancer via the activation of the Wnt/β-catenin signaling pathway.
Sun J; Zhang T; Cheng M; Hong L; Zhang C; Xie M; Sun P; Fan R; Wang Z; Wang L; Zhong J
J Exp Clin Cancer Res; 2019 Feb; 38(1):104. PubMed ID: 30813948
[TBL] [Abstract][Full Text] [Related]
14. TRIM29 as a prognostic predictor for multiple human malignant neoplasms: a systematic review and meta-analysis.
Liang C; Dong H; Miao C; Zhu J; Wang J; Li P; Li J; Wang Z
Oncotarget; 2018 Feb; 9(15):12323-12332. PubMed ID: 29552313
[TBL] [Abstract][Full Text] [Related]
15. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
16. TRIM29 is differentially expressed in colorectal cancers of different primary locations and affects survival by regulating tumor immunity based on retrospective study and bioinformatics analysis.
Han J; Zuo J; Zhang X; Wang L; Li D; Wang Y; Liu J; Feng L
J Gastrointest Oncol; 2022 Jun; 13(3):1132-1151. PubMed ID: 35837175
[TBL] [Abstract][Full Text] [Related]
17. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
18. TRIM29 as a novel biomarker in pancreatic adenocarcinoma.
Sun H; Dai X; Han B
Dis Markers; 2014; 2014():317817. PubMed ID: 24864129
[TBL] [Abstract][Full Text] [Related]
19. Loss of TRIM29 Alters Keratin Distribution to Promote Cell Invasion in Squamous Cell Carcinoma.
Yanagi T; Watanabe M; Hata H; Kitamura S; Imafuku K; Yanagi H; Homma A; Wang L; Takahashi H; Shimizu H; Hatakeyama S
Cancer Res; 2018 Dec; 78(24):6795-6806. PubMed ID: 30389700
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
